Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3efl | 706 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3efl | 706 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 1.000 | |
| 3hng | 8ST | Vascular endothelial growth factor receptor 1 | 2.7.10.1 | 0.657 | |
| 3cp9 | C19 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.632 | |
| 2qu6 | 857 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.620 | |
| 3vnt | 0JA | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.615 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.590 | |
| 4ase | AV9 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.586 | |
| 3dtw | A96 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.585 | |
| 5hi2 | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.584 | |
| 4fc0 | 0T2 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.581 | |
| 4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.574 | |
| 2p2i | 608 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.573 | |
| 4agw | NG7 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.573 | |
| 3vhk | BPK | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.566 | |
| 4ksp | 1SU | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.563 | |
| 2hyy | STI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.560 | |
| 4o2z | 046 | Mitogen-activated protein kinase | / | 0.557 | |
| 2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.556 | |
| 2xir | 00J | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.553 | |
| 1iep | STI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.549 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.549 | |
| 4aa0 | AA0 | Mitogen-activated protein kinase 14 | / | 0.546 | |
| 3hv5 | R24 | Mitogen-activated protein kinase 14 | / | 0.533 | |
| 2og8 | 1N8 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.520 | |
| 4eyj | N61 | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.520 | |
| 3kq7 | KQ7 | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.508 | |
| 4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.492 | |
| 4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.491 | |
| 4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.470 | |
| 3ce3 | 1FN | Hepatocyte growth factor receptor | 2.7.10.1 | 0.463 | |
| 4at5 | MUJ | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.460 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.447 | |
| 2dte | NAI | Glucose 1-dehydrogenase related protein | / | 0.445 | |
| 3gcs | BAX | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 3lfb | Z87 | Mitogen-activated protein kinase 14 | / | 0.444 |